Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Metadate_CD
gptkb:Methylin |
| gptkbp:acquisition |
Schwarz Pharma (2006)
Celltech (2004) Kremers Urban Pharmaceuticals (2014) |
| gptkbp:employees |
~7,500 (2020)
|
| gptkbp:focus |
neurology
immunology |
| gptkbp:founded |
1928
|
| gptkbp:founder |
Emile UCB
|
| gptkbp:headquarters |
gptkb:Brussels,_Belgium
|
| https://www.w3.org/2000/01/rdf-schema#label |
UCB, Inc.
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:partnership |
gptkb:Sanofi
gptkb:Pfizer gptkb:Amgen |
| gptkbp:products |
gptkb:Briviact
gptkb:Cimzia gptkb:Neupro |
| gptkbp:revenue |
€4.6 billion (2020)
|
| gptkbp:stock_exchange |
gptkb:Euronext_Brussels
|
| gptkbp:subsidiary |
gptkb:UCB_Pharma_Ltd.
|
| gptkbp:symbol |
gptkb:UCB
|
| gptkbp:website |
www.ucb.com
|